Cost Considerations in Selecting Coronary Artery Revascularization Therapy in the Elderly

Author： David M. Maziarz Theodore C. Koutlas

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.4, 2004-01, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revascularization treatment of stable coronary artery disease

By Magro Michael Garg Scot Serruys Patrick W

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 195-212

Informa Healthcare

Access to resources Recommend Favorite

Unique Coronary Artery Disease Differences in Women as Related to Revascularization

Current Medicinal Chemistry, Vol. 22, Iss. 31, 2015-10 ,pp. : 3597-3606

Bentham Science Publishers

Access to resources Recommend Favorite

Selecting Antibacterials for Outpatient Parenteral Antimicrobial Therapy: Pharmacokinetic-Pharmacodynamic Considerations

By Slavik R.S. Jewesson P.J.

Clinical Pharmacokinetics, Vol. 42, Iss. 9, 2003-01 ,pp. : 793-817

Adis International

Access to resources Recommend Favorite

Gene therapy for coronary and peripheral artery disease

By Nikol Sigrid

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 903-927

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Drug Therapy in the Elderly: Theoretical and Practical Considerations

By Williams B.R.

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 445-463

Adis International

Access to resources Recommend Favorite